The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluating the safety and efficacy of the addition of liver radiation (RT) to atezolizumab and bevacizumab (A/B) in advanced hepatocellular carcinoma (HCC): A retrospective cohort analysis.
 
Timothy J. Brown
No Relationships to Disclose
 
Uri Amit
No Relationships to Disclose
 
Edgar Ben-Josef
No Relationships to Disclose
 
Thomas Benjamin Karasic
Honoraria - AstraZeneca/MedImmune; Elevar Therapeutics; Incyte; Ipsen; Pfizer; Taiho Oncology
Consulting or Advisory Role - Incyte; Nucorion Pharmaceuticals
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); H3 Biomedicine (Inst); Incyte (Inst); Lilly (Inst); Taiho Pharmaceutical (Inst); Tempest Therapeutics (Inst); Totus Medicines (Inst); Xencor (Inst)